Live Webinar: Diversity & Access for Site Management Organisations

CM Industrial By CM LifeScience

Trials that have a more heterogeneous study population are more generalisable to clinical practice and potentially have more external validity. However, because of a number of societal and historical factors, it is a challenge for trials to achieve this desired heterogeneous population.

Find out how leading experts from the clinical trial space are combating these challenges by listening to this webinar!